Dr. Elica Kyoseva is a Quantum Computing Scientist at the German pharmaceutical company Boehringer Ingelheim, where she is working on advancing the drug discovery process through quantum computing. Her main focus is the extremely precise modeling of molecular systems that will enable new ways to discover drugs and thus will contribute to the global medical progress in the future. Elica has more than 15 years of experience in the field of quantum computing and has held leadership positions in academia, the private investments field, and currently, big pharma. Prior to joining BI, Elica was an MIT fellow and an entrepreneur in residence in a venture capital firm. Originally from Bulgaria, Elica currently lives in Israel.